image_1
Geneva Health Forum
______________________________________________________________
The repository of the key actors of global health in Geneva
image_1
image_2
With you
Together let's build the health of tomorrow
Promote innovative practices
Facilitate networking and collaborations
Develop solutions
image_2

  • show items with letter:
    A
  • show items with letter:
    B
  • show items with letter:
    C
  • show items with letter:
    D
  • show items with letter:
    E
  • show items with letter:
    F
  • show items with letter:
    G
  • show items with letter:
    H
  • show items with letter:
    I
  • show items with letter:
    J
  • show items with letter:
    K
  • show items with letter:
    L
  • show items with letter:
    M
  • show items with letter:
    N
  • show items with letter:
    O
  • show items with letter:
    P
  • no items with letter:
    Q
  • show items with letter:
    R
  • show items with letter:
    S
  • show items with letter:
    T
  • show items with letter:
    U
  • show items with letter:
    V
  • show items with letter:
    W
  • no items with letter:
    X
  • no items with letter:
    Y
  • no items with letter:
    Z
  • show items with letter:
    0-9

Medicines for Malaria Venture (MMV)

mmv
Developing antimalarials to save lives
 
Switzerland
Geneva
https://www.mmv.org
polle@mmv.org
Route de Pré-Bois 20, 1215 Geneva

 

 


Medicines for Malaria Venture (MMV), a not-for-profit public-private partnership in antimalarial drug research.

MMV was launched in 1999, with initial seed finance of US$4 million from the Government of Switzerland, the Department for International Development (UK), the Government of the Netherlands, The World Bank, and Rockefeller Foundation.

Its mission is to reduce the burden of malaria in disease-endemic countries by developing and facilitating the delivery of antimalarial drugs. Its vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate the disease.

MMV and partners manage a portfolio of over 65 projects, the largest portfolio of antimalarial R&D and access projects ever assembled.

 


  • International organization (except United Nations)

 


  • Infectious disease
  • Tropical disease

 


  • Medicines, vaccines

 


 


 

 

Located in: Medicines, vaccines | Infectious disease | Tropical disease | International organization (except United Nations) | Geneva